In a second set of experiments, we showed that targeting of both 99mTc-ANXA5 and 99mTc-DA5 to the ischemic muscle was blocked by administering 450 μg of unlabelled monomer ANXA5 prior to ischemia and the injection of labelled substrate (Figure 6C, D). This evidence concerns the gene ANXA5 and ischemia.